The activity reflects routine post-exercise tax settlements and minimal open-market selling, not a signal of distress. Traders should monitor for any follow-up open-market sales beyond tax events, but this cluster does not suggest negative sentiment.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 17 $540.02entry
- T+1 · 8mo ago −1.79%α −0.40% · $530.35
- T+5 · 8mo ago −1.52%α +1.11% · $531.82
- T+20 · 7mo ago +6.96%α +2.61% · $577.58
- T+60 · 5mo ago +1.00%α −8.99% · $545.40
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
United Therapeutics insiders executed a cluster of transactions over the past week, led by CEO Martine Rothblatt and other executives, primarily involving the exercise of derivative securities and tax-related share withholdings. The total value of open-market sales and tax withholding disposals exceeds $15.5 million, with the majority tied to non-cash exercises and tax settlements rather than discretionary selling.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt exercised over 100,000 derivative shares in multiple tranches, mostly at $0 cost, and sold 1,009 shares for $537,203 in open-market transactions.
- CFO James Edgemond and COO Michael Benkowitz each surrendered shares for tax withholding totaling $2.51M and $4.20M respectively after exercising derivatives.
- CEO Rothblatt surrendered 13,637 shares for tax withholding, valued at $7.31 million.
- Total value of share disposals (including tax withholding and open-market sales) exceeds $15.5 million over the 7-day period.
- Total open-market sales by insiders: $537,203 (CEO) + $24,008 (Director Malcolm) + $107,088 (Director Olian) = $668,299.
- Non-cash transactions (A, M, F) dominate the cluster, representing routine equity plan activity rather than active selling pressure.
Financial Impact
$15.5M in total share disposals over 7 days, including $668K in open-market sales and $14.8M in tax withholding from exercised options.
Risk Factors
- Large tax withholding events could signal upcoming reduced insider ownership if not offset by reinvestment.
- Perception risk: high-value share disposals may be misinterpreted as bearish despite being non-discretionary.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-UTHR-1773866106030 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers